
Long COVID and Digestive Symptoms: What the Research Tells Us
Research summary exploring digestive manifestations of Long COVID, including gut microbiome changes, IBS risk and potential treatment approaches.
Guidance title: Long Covid and Menopause (RCN Guidance, 2026) Authors & year: Royal College of Nursing, 2026
Journal / source: RCN / Nursing Practice Academy
Link to full paper: https://www.rcn.org.uk/Professional-Development/publications/menopause-and-long-covid-uk-pub-012-346
Note: This is a summary of a clinical guidance document (not a single research study). It brings together evidence, clinical expertise, and national guidance (e.g. National Institute for Health and Care Excellence (NICE), Office for National Statistics (ONS), World Health Organization (WHO)).
Long COVID and menopause share many symptoms, making it difficult to distinguish between them. Care should consider both conditions and be individualised
This means symptoms may be:
This guidance brings together current evidence, clinical expertise, and existing guidance frameworks to highlight key points:
Who does this apply to?
Women, particularly those aged 35–64
Those with:
| LONG COVID | MENOPAUSE |
|---|---|
| Fatigue | Fatigue |
| Brain fog | Brain fog |
| Anxiety | Low mood/anxiety |
| Sleep problems | Insomnia |
| Feeling hot/cold | Hot flushes/night sweats |
| Breathlessness | Palpitations |
| Muscle aches | Joint pain |
| Headaches | Headaches/migraines |
| Sexual dysfunction | Loss of libido |
(Adapted from Table1: Common symptom)
Key Point: Many symptoms overlap, making it difficult to identify the underlying cause through clinical assessment alone.
1. Women are disproportionately affected
2. Symptoms are difficult to separate
3. Symptoms may fluctuate over time and with activity or physiological changes
4. Diagnosis is clinically challenging
5. Care requires a holistic approach
How should this be interpreted?
This is a clinical guidance document rather than a single research study. It brings together observational evidence, clinical expertise, and national guidance to support understanding and management. The evidence base is still evolving, and some recommendations are based on clinical judgement where evidence is limited.
Management and support
The guidance highlights that management may require a combination of approaches, including physical, psychological, and occupational support. It emphasises that care is typically individualised rather than based on a single intervention.
Key idea: No single intervention is sufficient – care should be individualised and integrated
Long COVID and menopause can present with similar symptoms, making assessment and management more complex. Recognising this overlap may help improve understanding of symptom patterns and support more personalised care.
Symptoms such as fatigue, poor sleep, and cognitive changes may have more than one contributing cause. Both Long COVID and menopause should be considered during clinical assessment.

Research summary exploring digestive manifestations of Long COVID, including gut microbiome changes, IBS risk and potential treatment approaches.

Returning to work is often viewed as a major milestone in recovery. However, for many people living with Long COVID, returning to work does not necessarily mean returning to their previous level of health. This study by Su and colleagues explored the experiences of 79 adults living with Long COVID who had returned to employment. […]

Learn why the precautionary principle is fundamental to infection prevention and how its application protects healthcare workers and patients.